The only known exception is the deletion of CUL3 exon 9 by a specific dominant splice site variant causing a severe form of pseudohypoaldosteronism type II (PHAII), featuring hypertension, hyperkalemia, and metabolic acidosis but not ASD15–17. The gene discussed is CUL3; the disease is pseudohypoaldosteronism type 2.